Bolt Biotherapeutics, Inc. (BOLT)

NASDAQ: BOLT · IEX Real-Time Price · USD

1.100

0.00 (0.00%)

At close: May 3, 2024, 4:00 PM

1.120

+0.020 (1.82%)

After-hours: May 3, 2024, 4:42 PM EDT

Bolt Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	42	43	49	183	-	-	-
Market Cap Growth	-	-13.15%	-73.20%	-	-	-	-
Enterprise Value	-42	-41	-99	19	-14	-25	-14
PE Ratio	-0.61	-0.61	-0.56	-1.85	-	-	-
PS Ratio	5.33	5.40	8.55	145.00	-	-	-
PB Ratio	0.37	0.38	0.28	0.73	-	-	-
P/FCF Ratio	-0.61	-0.61	-0.62	-3.08	-	-	-
P/OCF Ratio	-0.61	-0.61	-0.64	-3.20	-	-	-
EV/Sales Ratio	-5.23	-5.23	-17.26	15.29	-58.55	-117.33	-
EV/EBITDA Ratio	0.64	0.64	1.19	-0.20	0.23	0.87	1.20
EV/EBIT Ratio	0.60	0.60	1.12	-0.20	0.22	0.83	1.17
EV/FCF Ratio	0.59	0.59	1.26	-0.32	0.27	0.94	1.34
Debt / Equity Ratio	0.18	0.18	0.13	0.10	-0.10	-0.22	0.00
Debt / EBITDA Ratio	-0.31	-0.31	-0.27	-0.26	-0.19	-0.35	0.00
Debt / FCF Ratio	-0.29	-0.29	-0.29	-0.41	-0.22	-0.38	0.00
Quick Ratio	5.08	5.08	7.37	8.80	2.17	4.09	4.95
Current Ratio	5.17	5.17	7.47	8.87	2.25	4.15	5.12
Asset Turnover	0.04	0.04	0.02	0.00	0.01	0.01	-
Return on Equity (ROE)	-51.20%	-51.20%	-44.30%	-35.10%	80.50%	98.70%	-
Return on Assets (ROA)	-37.80%	-37.80%	-34.70%	-30.00%	-127.90%	-94.60%	-
Return on Capital (ROIC)	-57.31%	-57.31%	-46.53%	-33.81%	52.28%	86.84%	73.12%
Earnings Yield	-164.99%	-162.73%	-179.94%	-53.96%	-	-	-
FCF Yield	-166.26%	-163.99%	-160.25%	-32.52%	-	-	-
Buyback Yield / Dilution	-1.21%	-1.21%	-12.54%	-1479.05%	-5.46%	-20.76%	-
Total Shareholder Return	-1.21%	-1.21%	-12.54%	-1479.05%	-5.46%	-20.76%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).